Business
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director.
About this update from Krtl Holding Group, Inc
[{"type":"text","content":"KRTL Holding Group, Inc. (OTC: KRTL) is pleased to announce the appointment of Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director. A distinguished leader in the pharmaceutical and commercial sector, Patricia brings more than 50 years of industry expertise, driving pharmaceutical innovation, market expansion, and regulatory compliance across Latin America and global markets.As CEO and Majority Shareholder of Industria Quimico Farmaceutica Sigma Corp. (Sigma Corp.), Patricia has played a pivotal role in transforming Bolivia's pharmaceutical landscape, overseeing regulatory advancements, and spearheading international trade initiatives. Under her leadership, Sigma Corp. expanded its manufacturing capabilities, establishing state-of-the-art pharmaceutical infrastructure compliant with European export standards, and positioning the company to be a regional powerhouse in API production, research, and global distribution.With this appointment, Patricia will be responsible for KRTL's global pharmaceutical sales strategy, leading market penetration efforts, developing key strategic alliances, and ensuring KRTL's compliance-driven expansion in regulated pharmaceutical and biopharmaceutical markets. She will collaborate closely with KRTL Biotech and KRTL International to integrate global trade, regulatory expertise, and pharmaceutical supply chain efficiency into KRTL's commercial strategy.\"Marlen Patricia Wilstermann-Sanzetenea's appointment is a milestone for KRTL's global expansion,\" said Cesar Herrera, CEO of KRTL Holding Group Inc. \"Her deep industry knowledge, regulatory expertise, and ability to navigate complex international markets make her an invaluable addition to our leadership team. With her guidance, KRTL will strengthen its position in pharmaceutical innovation and global distribution.\"Patricia's leadership will be instrumental in scaling KRTL's pharmaceutical sales division, leveraging her experience in strategic business development, international compliance, and API commercialization. Her proven track record of market growth, regulatory structuring, and pharmaceutical innovation aligns with KRTL's commitment to scientific excellence, regulatory transparency, and sustainable business expansion.About KRTL Holding Group Inc.KRTL Holding Group Inc. is a dynamic holding company operating ...